首页> 外文OA文献 >Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer

【2h】

Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer

机译：吉西滨 - 顺铂和Capecitabine-Cisplatin组合化疗治疗晚期胆道癌的疗效比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jieun Lee; Tae Ho Hong; In Seok Lee; Young Kyoung You; Myung Ah Lee;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Single-institution experience with gemcitabine-cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine-S-1 combination therapy: a prospective feasibility study [J] . Matsuyama Ryusei, Morioka Daisuke, Mori Ryutaro, Cancer chemotherapy and pharmacology. . 2018,第5期

机译：吉西他滨 - 顺铂联合治疗的单机制经验作为吉西他滨-S-1组合治疗失败后不可切除的胆道癌患者的二线治疗：预期可行性研究
2. Single-institution experience with gemcitabine-cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine-S-1 combination therapy: a prospective feasibility study [J] . Matsuyama Ryusei, Morioka Daisuke, Mori Ryutaro, Cancer chemotherapy and pharmacology. . 2018,第5期

机译：用吉西滨 - 顺铂组合治疗的单机制经验作为吉西他滨-S-1组合治疗失败后不可切除的胆道癌患者的二线治疗：预期可行性研究
3. Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial). [J] . Takuji Okusaka, Makoto Ueno, Tosiya Sato, Journal of hepato-biliary-pancreatic sciences . 2012,第4期

机译：胆道癌免疫治疗的可能性：我们如何证明疗效？介绍当前正在进行的I期和II期随机研究，以评估在吉西他滨和顺铂中添加Wilms肿瘤1肽疫苗治疗晚期胆道癌的有效性和安全性（WT-BT试验）。
4. Efficacy of combination chemotherapy with docetaxel and irinotecan as first- or second-line treatment for advanced gastric cancer [C] . K. Sugiyama, A. Ishikawa, T. Watanabe International Gastric Cancer Congress . 2009

机译：组合化疗与多西紫杉醇和伊替康的疗效，作为晚期胃癌的第一或二线治疗
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer [O] . Jieun Lee, Tae Ho Hong, In Seok Lee, 2015

机译：吉西他滨-顺铂和卡培他滨-顺铂联合化疗治疗晚期胆道癌的疗效比较
7. Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract. [O] . Song YS, Cho JS, Cho KS, 2011

机译：吉西他滨-顺铂辅助化疗的疗效：局部晚期膀胱移行细胞癌与上尿路的比较研究。

Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅